# Effects of Beta-blockade on Platelet Aggregation in Acute Coronary Syndrome

Study · id `cardio:ct-nct02809820` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02809820](<https://clinicaltrials.gov/study/NCT02809820>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02809820

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT02809820. Randomized; no masking; primary purpose basic science. Start 2016-05 (registry gives no type); primary completion 2016-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose basic science
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT02809820, source copy `cardio:ctgov-nct02809820-2022-03-31`, retrieved 2026-10-31)
- Start date: 2016-05 (registry gives no type) (ClinicalTrials.gov record NCT02809820, source copy `cardio:ctgov-nct02809820-2022-03-31`, retrieved 2026-10-31)
- Primary completion: 2016-12 (actual) (ClinicalTrials.gov record NCT02809820, source copy `cardio:ctgov-nct02809820-2022-03-31`, retrieved 2026-10-31)
- Completion: 2016-12 (actual) (ClinicalTrials.gov record NCT02809820, source copy `cardio:ctgov-nct02809820-2022-03-31`, retrieved 2026-10-31)
- Countries: Italy (ClinicalTrials.gov record NCT02809820, source copy `cardio:ctgov-nct02809820-2022-03-31`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02809820-2022-03-31`, retrieved 2026-10-31)

## The registry's words

- Brief title: Effects of Beta-blockade on Platelet Aggregation in Acute Coronary Syndrome
- Acronym: PLATE-BLOCK
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Carvedilol
- Intervention (Drug): Metoprolol
- Lead sponsor: Federico II University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention name matches this record: Carvedilol (`cardio:carvedilol`)
- Registry intervention name matches this record: Metoprolol (`cardio:metoprolol`)
- Registry intervention is a member of this class by a sourced record link: Beta-blockers (drug class) (`cardio:beta-blockers`)
- Registry lists this organization as the lead sponsor: Federico II University (`cardio:org-federico-ii-university`)

## Provenance

Content hash: a1c3fdbb6fd24763a8ac3184a376482e5fe9cc573fa46b05d2520090a69980c2
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
